Cargando…

Efficacy and Prognostic Analysis of 315 Stage I–IVa Esophageal Cancer Patients Treated with Simultaneous Integrated Boost-Intensity-Modulated Radiation Therapy

PURPOSE: Use of simulated integrated boost-intensity-modulated radiation therapy (SIB-IMRT) is rarely reported in the treatment of esophageal cancer. This study was performed to observe the curative effect and prognostic factors associated with concurrent chemoradiotherapy for esophageal cancer usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Peng, Yang, Yan, Li, Duo-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434855/ https://www.ncbi.nlm.nih.gov/pubmed/34522139 http://dx.doi.org/10.2147/CMAR.S329625

Ejemplares similares

The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy
por: Wakatsuki, Masaru, et al.
Publicado: (2016)

Efficacy and Safety of Simultaneous Integrated Boost Intensity-Modulation Radiation Therapy Combined with Systematic and Standardized Management for Esophageal Cancer
por: Deng, Wenzhao, et al.
Publicado: (2022)

Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity
por: Ristau, J., et al.
Publicado: (2021)

Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous esophageal cancer: a retrospective cohort study
por: Zhou, Shixiang, et al.
Publicado: (2023)

Monte Carlo dose verification of prostate patients treated with simultaneous integrated boost intensity modulated radiation therapy
por: Dogan, Nesrin, et al.
Publicado: (2009)

An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy
por: Ma, Li, et al.
Publicado: (2018)

Feasibility of simultaneous integrated boost with forward intensity-modulated radiation therapy for multiple brain metastases
por: Ni, Lingqin, et al.
Publicado: (2014)

T315I-mutated myeloid sarcoma
por: Zhang, Yumeng, et al.
Publicado: (2019)

Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2018)

Simultaneous integrated boost of intensity‐modulated radiation therapy to Stage II‐III non‐small cell lung cancer with metastatic lymph nodes
por: Li, Qing‐Song, et al.
Publicado: (2020)

Radiation therapy for stage IVA uterine cervical cancer: treatment outcomes including prognostic factors and risk of vesicovaginal and rectovaginal fistulas
por: Hata, Masaharu, et al.
Publicado: (2017)

Treatment options for stage IVA thymic malignancies
por: Girard, Nicolas
Publicado: (2019)

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
por: Yamazaki, Takahiro, et al.
Publicado: (2021)

Different definitions of esophagus influence esophageal toxicity prediction for esophageal cancer patients administered simultaneous integrated boost versus standard-dose radiation therapy
por: Huang, Bao-tian, et al.
Publicado: (2017)

Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries
por: Tiwari, Vivek, et al.
Publicado: (2015)

Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
por: Wang, Fangzheng, et al.
Publicado: (2020)

Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin
por: Lachkar, Bouchra, et al.
Publicado: (2018)

Pagos mensuales del I.V.A. /
por: Domínguez Orozco, Jaime
Publicado: (2000)

A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer
por: Li, Chen, et al.
Publicado: (2019)

Effect of different surgical approaches on the prognosis of patients with postoperative radiotherapy for stage IIB–IVA esophageal squamous cancer
por: Gao, Mingcheng, et al.
Publicado: (2022)

The Prognostic Value of Deficient Mismatch Repair in Stage II–IVa Nasopharyngeal Carcinoma in the Era of IMRT
por: Chen, Fang-ming, et al.
Publicado: (2020)

Surgical Approaches for Stage IVA Thymic Epithelial Tumors
por: Shapiro, Mark, et al.
Publicado: (2014)

Radiotherapy for stage IVa thymoma—Shanghai Chest experience
por: Wang, Changlu, et al.
Publicado: (2019)

Whole breast and excision cavity radiotherapy plan comparison: Conformal radiotherapy with sequential boost versus intensity-modulated radiation therapy with a simultaneously integrated boost
por: Small, Katherine, et al.
Publicado: (2013)

Stage IIB-IVA cervix carcinoma in elderly patients treated with radiation therapy: a longitudinal cohort study by propensity score matching analysis
por: Shou, Huafeng, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
por: Pontoriero, Antonio, et al.
Publicado: (2020)

Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
por: Yi, Junlin, et al.
Publicado: (2014)

Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer
por: Han, Dan, et al.
Publicado: (2014)

Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer
por: Mineur, Laurent, et al.
Publicado: (2023)

T315I(+) tyrosine-kinase independent CML cells resistance
por: Nicolini, Franck Emmanuel, et al.
Publicado: (2017)

Indolent stage IVA thymic malignancies managed with multimodality treatments
por: Hamaji, Masatsugu
Publicado: (2020)

Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life
por: Pasquier, David, et al.
Publicado: (2019)

Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Clinically Node-Positive Prostate Cancer: A Single-Institutional Retrospective Study
por: Onishi, Masahiro, et al.
Publicado: (2021)

Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial
por: Ricco, Anthony, et al.
Publicado: (2020)

Toxicity of Tomotherapy-Based Simultaneous Integrated Boost in Whole-Pelvis Radiation for Prostate Cancer
por: You, Sei Hwan, et al.
Publicado: (2015)

Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction
por: Yaremko, Brian P, et al.
Publicado: (2013)

Prognostic evaluation of esophageal cancer patients with stages I-III
por: Qiu, Meng-jun, et al.
Publicado: (2020)

Diagnosing mucopolysaccharidosis IVA
por: Wood, Timothy C., et al.
Publicado: (2013)

Reviewers BJCVS 31.5
Publicado: (2016)

Health Tract No. 315: Presentiments
Publicado: (1868)

Cannot write session to /tmp/vufind_sessions/sess_5v3i3jg28a5dncsh5faqdntvv8